Latest Neurology Stories
CHICAGO, Feb. 18, 2013 /PRNewswire-USNewswire/ -- First diagnosed with epilepsy when she was 17 years old, Ann O'Shea experienced one to two seizures a year before getting her condition under control with a medication called lamotrigine. When she decided to go on birth control at age 22, very little was explained to her about the impact it could have on her epilepsy medication. Within two months, O'Shea had three seizures - far more than what she had experienced in the past....
Diclofenac most commonly used non-steroidal anti-inflammatory drug in 15 countries, listed on 74 national drug lists, despite cardiovascular risks A study in this week's PLOS Medicine finds that the painkiller diclofenac (a non-steroidal anti-inflammatory drug (NSAID) in the same class as aspirin) is the most commonly used NSAID in the 15 countries studied and is included in the essential medicines lists of 74 low-, middle- and high-income countries, despite its known tendency to cause...
[ Video 1 ] | [ Video 2 ] Alan McStravick for redOrbit.com - Your Universe Online The mammalian retina is a masterful example of genetic engineering. Each moment our eyes are open, we take in mountains and mountains of data that has to be pored over, interpreted and processed by a specific cortical region within our brains. Despite their seemingly endless capabilities, even our retinas have their limits. That is, until today, with the release of a new study by researchers led by Duke...
TORONTO, Feb. 13, 2013 /CNW/ - Alzheimer's research received a huge boost today as one of Canada's iconic brands Mother Parkers donated $1 million to the Alzheimer Society of Canada. The donation represents the single largest contribution to the Alzheimer Society Research Program (ASRP), a peer-reviewed grant and awards program that supports Canada's top talent in bio-medical and quality-of-life research to find a cure for Alzheimer's disease and improve day-to-day care. The...
LOS ANGELES, Feb. 11, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that Christopher DeGiorgio, M.D., Vice President of Neurology at NeuroSigma and Professor of Neurology at the University of California, Los Angeles (UCLA), and Colin Kealey, M.D., Manager of Business Development at NeuroSigma, will present in London, an overview of external trigeminal nerve stimulation (eTNS(TM)) for the treatment of epilepsy and depression at The...
MINNEAPOLIS, Feb. 7, 2013 /PRNewswire-USNewswire/ -- You can now vote for your favorite video entry to the 2013 Neuro Film Festival at http://www.NeuroFilmFestival.com. The Neuro Film Festival is a contest by the American Brain Foundation, the foundation of the American Academy of Neurology, to help raise awareness about why more research is needed to cure brain diseases such as Alzheimer's disease, stroke, autism, Parkinson's disease and multiple sclerosis. Public voting will...
LIEGE, Belgium, February 7, 2013 /PRNewswire/ -- The American scientific journal NEUROLOGY publishes the positive results of the PREMICE clinical study on the effectiveness and safety of the CEFALY(R) medical device in the prevention of migraine. NEUROLOGY (official journal of the American Academy of Neurology, the number one among the most-cited journals worldwide in the field of neurology) is publishing the results of the multi-centre PREMICE clinical study...
Wearing a nerve stimulator for 20 minutes a day may be a new option for migraine sufferers, according to new research published in the February 6, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The stimulator is placed on the forehead, and it delivers electrical stimulation to the supraorbital nerve. For the study, 67 people who had an average of four migraine attacks per month were followed for one month with no treatment. Then they...
CINCINNATI, Feb. 4, 2013 /PRNewswire-USNewswire/ -- Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Posted online in PNAS Early Edition on Feb. 4, the study was led by scientists at Cincinnati Children's Hospital Medical Center. "This study provides a...
LOS ANGELES, Feb. 4, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced it received a Notice of Award, for a Fast Track Small Business Innovation Research (SBIR) grant, from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Phase I of the project is budgeted in the amount of $600,000, with $3 Million budgeted for Phase II, subject to the availability of funds and satisfactory...
Latest Neurology Reference Libraries
Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
